within subject standard deviation in fully replicate design if carry over effect is present [General Sta­tis­tics]

posted by dshah  – India, 2023-06-14 12:37 (701 d 06:14 ago) – Posting: # 23591
Views: 2,953

Hello Ankit!

As per PSG, the recommendation is parallel study.

[image]

❝ So how to calculate Swr when unequal carryover effect is present in full replicate study design?


Moreover, the study population is patient and you can not stop the treatment. So why fully replicate CO study?

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
145 visitors (0 registered, 145 guests [including 5 identified bots]).
Forum time: 18:51 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5